KANSAS CITY, Kan., June 25, 2024 (GLOBE NEWSWIRE) -- In alignment with U.S. Food and Drug Administration (FDA) requirements, Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its ...
3'-deoxy-3'-[18F]fluorothymidine position emission tomography for target delineation in resected malignant gliomas before radiotherapy. This is an ASCO Meeting Abstract from the 2013 ASCO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback